Virtus LifeSci Biotech Clinical Trials ETF
BBC
BBC
10 hedge funds and large institutions have $4.08M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
9% less funds holding
Funds holding: 11 → 10 (-1)
Holders
10
Holding in Top 10
–
Calls
$554K
Puts
–
Top Buyers
| 1 | +$907K | |
| 2 | +$640K | |
| 3 | +$284K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$99K |
| 5 |
Morgan Stanley
New York
|
+$62.4K |